New York, NY -- (SBWIRE) -- 01/13/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: -- Banco Santander Brasil SA (ADR)(NYSE:BSBR), Brocade Communications Systems, Inc.(NASDAQ:BRCD), Synta Pharmaceuticals Corp.(NASDAQ:SNTA),National Bank of Greece (ADR)(NYSE:NBG)
Banco Santander Brasil SA (ADR)(NYSE:BSBR) reported gain 1.49% and closed at $5.25 with the total traded volume of 4.93M shares. Its market capitalization is $19.95B. The stock has a 52-week high price of 8.19 and its 52-week low was recorded at $5.15
Banco Santander Brasil SA (the Bank) is a Brazil-based bank. The Bank operates as a multiple service bank through three business segments: Commercial Bank, Global Wholesale Bank and Asset Management and Insurance.
What BSBR Charts Are Signaling for Traders? Find Out Here
Brocade Communications Systems, Inc.(NASDAQ:BRCD) gain 0.43% and ended at $9.28.The total traded volume was 4.86M shares and market capitalization arrived at $4.12B. The stock has a 52-week high price of $9.30 and its 52-week low was recorded at $5.14 while during last trade its minimum price was $9.12 and it gained the highest price of $9.30.
Brocade Communications Systems, Inc. (Brocade) is a supplier of networking equipment, including end-to-end Internet Protocol-based Ethernet networking solutions and storage area networking solutions for businesses and organizations of all types and sizes, including global enterprises, and service providers, such as telecommunication firms
Is BRCD Buy After The Recent Price Movement? Find Out Here
Synta Pharmaceuticals Corp.(NASDAQ:SNTA)’s reported the increase of 10.82% to close at $6.45 with the overall traded volume of 4.57M shares. Its market capitalization on last close reached to $549.56 million. Its intraday-low price was $6.12 and its hit its day's highest price at $6.49.
Synta Pharmaceuticals Corp. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing small molecule drugs to severe the medical conditions of the patients with cancer and inflammatory diseases.
Should SNTA a Buy or Sell Now? Find Out Here
National Bank of Greece (ADR)(NYSE:NBG) loss -0.51% settle at $5.84. Its total traded volume during last trading session was 4.53M shares. The overall market worth of this company is about $13.99B. The 52 week range of the stock remained $2.85 - $24.70, while its day's lowest price was $5.73 and its hit its day's highest price at $5.98.
National Bank of Greece SA (the Bank) is a Greece-based financial institution. It provides a range of financial services including retail and commercial banking, asset management, brokerage, investment banking, insurance and real estate at a global level.
What NBG Charts Are Signaling for Traders? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)